InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Mates Sharon, Chairman & CEO. Officer active across 1 company, notably Intra-Cellular Therapies, Inc.. In total, 29 filings have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €5.1m. History available since 23 August 2021. The latest transaction was disclosed on 2 April 2025 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Declarations29 total
945,235 shares@ US$132.0092.8% of flowCommon StockSEC:0000950170-25-049595:0
190,000 shares0Common StockSEC:0000950170-25-047937:0
40,712 sharesCommon StockSEC:0000950170-25-036593:0
34,969 sharesCommon StockSEC:0000950170-25-032587:0
30,847 shares0Common StockSEC:0000950170-25-013765:0
51,000 shares@ US$12.730.5% of flowCommon StockSEC:0000950170-24-134240:0
35,604 shares@ US$12.730.3% of flowCommon StockSEC:0000950170-24-102475:0
22,713 shares@ US$17.570.3% of flowCommon StockSEC:0000950170-24-101506:0
53,013 shares@ US$17.570.7% of flowCommon StockSEC:0000950170-24-100275:0
8,638 shares@ US$16.860.1% of flowCommon StockSEC:0000950170-24-048467:0
31,958 shares@ US$66.381.6% of flowCommon StockSEC:0000950170-24-029583:0
40,712 sharesCommon StockSEC:0000950170-24-028822:0
22,590 sharesCommon StockSEC:0000950170-24-021568:0
33,885 shares0Common StockSEC:0000950170-24-011398:0
75,361 shares@ US$16.860.9% of flowCommon StockSEC:0000950170-24-005557:0
27,468 shares@ US$53.5541.1% of flowCommon StockSEC:0001209191-23-050101:0
41,770 shares0Common StockSEC:0001209191-23-018283:0
22,590 sharesCommon StockSEC:0001209191-23-013434:0
27,848 sharesCommon StockSEC:0001209191-23-011982:0
33,083 shares@ US$55.001.4% of flowCommon StockSEC:0001209191-22-061532:0
38,925 shares@ US$2.8441.0% of flowCommon StockSEC:0001209191-22-017858:0
22,589 sharesCommon StockSEC:0001209191-22-013346:0
27,847 sharesCommon StockSEC:0001209191-22-012385:0
41,896 sharesCommon StockSEC:0001209191-22-002984
41,896 sharesCommon StockSEC:0001209191-22-002984:0
25 of 29 declarations
About Mates Sharon
Sharon Mates is the Chairman, President, and CEO of Intra-Cellular Therapies, Inc. She leads the company in its efforts to develop innovative treatments for psychiatric disorders, focusing on research and development.
